BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6087399)

  • 1. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
    Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
    Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia associated with an elevated 1,25 dihydroxy vitamin D3 level and an elevated angiotensin-converting enzyme level in a patient without evidence of sarcoidosis or malignancy.
    Friedman NS
    Md Med J; 1994 May; 43(5):439-42. PubMed ID: 8052095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity.
    Meyrier A; Valeyre D; Bouillon R; Paillard F; Battesti JP; Georges R
    Q J Med; 1985 Mar; 54(215):269-81. PubMed ID: 3838815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men.
    Kimball S; Vieth R
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):106-10. PubMed ID: 18275686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.
    Lavender TW; Martineau AR; Quinton R; Schwab U
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):140. PubMed ID: 22236861
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated 25-hydroxy and normal 1,25-dihydroxy cholecalciferol serum concentrations in a successfully-treated case of vitamin D3 toxicosis in a dog.
    Scheftel J; Setzer S; Walser M; Pertile T; Hegstad RL; Felice LJ; Murphy MJ
    Vet Hum Toxicol; 1991 Aug; 33(4):345-8. PubMed ID: 1654665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
    Theiler R; Bischoff H; Tyndall A; Stähelin HB
    Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production of calcitriol, and hypercalcaemia in a patient with sarcoidosis provoked by daily intake of calciol.
    Boon ES; Cozijn D; Brombacher PJ
    Eur J Clin Chem Clin Biochem; 1993 Oct; 31(10):679-81. PubMed ID: 8292670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecalciferol modulates plasma phosphate but not plasma vitamin D levels and intestinal phosphate absorption in rainbow trout (Oncorhynchus mykiss).
    Avila EM; Basantes SP; Ferraris RP
    Gen Comp Endocrinol; 1999 Jun; 114(3):460-9. PubMed ID: 10336834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of calcium in sarcoidosis].
    Podwysocki B
    Postepy Hig Med Dosw; 1994; 48(2):193-206. PubMed ID: 7937400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercalcemia in sarcoidosis].
    Janssen JA; Pols HA; Baggen MG; Birkenhäger JC
    Ned Tijdschr Geneeskd; 1989 Dec; 133(48):2399-402. PubMed ID: 2586678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol-mediated hypercalcemia: causes and course in 101 patients.
    Donovan PJ; Sundac L; Pretorius CJ; d'Emden MC; McLeod DS
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4023-9. PubMed ID: 23979953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D replacement therapy in patients with the nephrotic syndrome.
    Haldimann B; Trechsel U
    Miner Electrolyte Metab; 1983; 9(3):154-6. PubMed ID: 6308412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcaemia and elevated 1,25-dihydroxy-vitamin D3 levels in a patient with multibacillary leprosy and a type I leprosy reaction.
    Fraser AG; Croxson MS; Ellis-Pegler RB
    N Z Med J; 1987 Feb; 100(817):86. PubMed ID: 3469558
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
    J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis mimicking toxoplasmosis with severe hypercalcaemia and normal 1,25-dihydroxy vitamin D.
    Levy Y; Hayek T; Finkelstein R
    J Intern Med; 1996 Sep; 240(3):165-7. PubMed ID: 8862127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin-converting enzyme and 1,25-dihydroxyvitamin D3 in hypercalcemia of unknown origin].
    Leidig P; Baum HP; Krakamp B; Finke K; Bönner G
    Dtsch Med Wochenschr; 1988 Dec; 113(51-52):2003-6. PubMed ID: 2849536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.